New Drug Offers Hope for Patients with Rare Bone Disorder F.O.P.

Fibrodysplasia ossificans progressiva (F.O.P.) is a rare genetic condition characterized by uncontrolled bone growth. A newly developed drug shows promise in slowing or stopping this process, offering hope to affected patients. This development marks a significant advancement in treating a previously untreatable disease.

Originally published by nyt